Release Date: 27/08/12 18:39 Summary: 4E and Full Year Financial Report Price Sensitive: Yes Download Document 1.72MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%